Recurrence of hepatocellular carcinoma.

Although the treatment of hepatocellular carcinoma is evolving, hepatic resection remains the treatment of choice for many patients. Resection is associated with a 5-year survival rate of 50% but also a 70% recurrence rate.1–3 Thus, for most patients, resection is not a cure. Recurrence of hepatocellular carcinoma after resection or local ablation with heat generated by high-frequency radio waves can be classified as early or late. Early recurrence occurs within weeks or months after treatment and has been attributed to either incomplete initial treatment or micrometastases within the liver but outside the treated field. Late recurrence, defined as recurrence . . .

[1]  Kenji Ikeda,et al.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.

[2]  J. Bousquet,et al.  Effect of 17q21 variants and smoking exposure in early-onset asthma. , 2008, The New England journal of medicine.

[3]  E. Burchard,et al.  ORMDL3 gene is associated with asthma in three ethnically diverse populations. , 2008, American journal of respiratory and critical care medicine.

[4]  C. Palmer,et al.  A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. , 2008, The Journal of allergy and clinical immunology.

[5]  E. Gelfand.  Is asthma in childhood different from asthma in adults? Why do we need special approaches to asthma in children? , 2008, Allergy and asthma proceedings.

[6]  D. Vercelli,et al.  Discovering susceptibility genes for asthma and allergy , 2008, Nature Reviews Immunology.

[7]  Gonçalo R. Abecasis,et al.  Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.

[8]  V. Mazzaferro,et al.  A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. , 2006, Gastroenterology.

[9]  F. Martinez.  Toward asthma prevention--does all that really matters happen before we learn to read? , 2003, The New England journal of medicine.

[10]  Masatoshi Tanaka,et al.  Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  T. Roskams,et al.  Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non‐cirrhotic and cirrhotic chronic viral hepatitis , 2001, Histopathology.

[12]  G. Ercolani,et al.  Improved Results of Liver Resection for Hepatocellular Carcinoma on Cirrhosis Give the Procedure Added Value , 2001, Annals of surgery.

[13]  H. Yamagishi,et al.  Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X‐chromosome locus , 2000, Hepatology.

[14]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[15]  W. Jarnagin,et al.  An analysis of 412 cases of hepatocellular carcinoma at a Western center. , 1999, Annals of surgery.

[16]  M. Roncalli,et al.  Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. , 1995, Gastroenterology.

[17]  T. Aihara,et al.  Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis. , 1994, Gastroenterology.

[18]  S. Hirohashi,et al.  Predictive factors for postoperative recurrence of hepatocellular carcinoma. , 1994, Gastroenterology.

[19]  O. Hino,et al.  Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules. , 1992, Cancer research.

[20]  Y. Morioka,et al.  Postoperative Recurrence of Hepatocellular Carcinoma , 1990, Annals of surgery.

[21]  Frieda Brim Wallin,et al.  The predictive factors. , 1941 .